Similarly, prostate cancer has also been thought to be linked to KDM1A due to KDM1A-mediated transcriptional regulation of AR, and KDM1A inhibition decreases prostate cancer proliferation (Zhang et al., 2009; Willmann et al., 2012). This evidence concerns the gene AR and prostate carcinoma.